Table 2 Age-standardized YLL, YLD, DALY rates and percentage change for Level 2 NCD-group, in Cyprus from 1990 to 2017
YLLs | YLDs | DALYs | |||||||
|---|---|---|---|---|---|---|---|---|---|
1990 age-standardized rates per 100,000 | 2017 age-standardized rates per 100,000 | Percentage change in age-standardized rates per 100,000 | 1990 age-standardized rates per 100,000 | 2017 age-standardized rates per 100,000 | Percentage change in age-standardized rates per 100,000 | 1990 age-standardized rates per 100,000 | 2017 age-standardized rates per 100,000 | Percentage change in age-standardized rates per 100,000 | |
All causes | 14,614 (14,339 - 14,887) | 7904 (7332 - 8540) | −45.9% | 10,597 (7972 - 13,641) | 10,383 (7841 - 13,374) | − 2.0% | 25,211 (22,605 - 28,229) | 18,287 (15,607 - 21,322) | −27.5% |
Group II: Non-communicable diseases | 10,793 (10,484 - 11,096) | 6345 (5892 - 6856) | −41.2% | 8815 (6608 - 11,395) | 8785 (6592 - 11,303) | − 0.3% | 19,608 (17,362 - 22,248) | 15,129 (12,809 - 17,707) | −22.8% |
Cardiovascular diseases | 4583 (4428 - 4752) | 2171 (1981- 2389) | −52.6% | 397.1 (291.5–516.6) | 326.2 (241–420.6) | −17.9% | 4980 (4787 - 5183) | 2497 (2276- 2729) | −49.9% |
Neoplasms | 2718 (2592 - 2828) | 2327 (2150- 2523) | −14.4% | 81.7 (59.8–105.7) | 142.2 (103.3–189.4) | 74.1% | 2800 (2673 - 2916) | 2469 (2277- 2681) | −11.8% |
Musculoskeletal disorders | 41.9 (30.3–51.3) | 27 (20–32) | −34.7% | 2337 (1700 - 3151) | 2337 (1692 - 3152) | 0.0% | 2379 (1740 - 3187) | 2365 (1719 - 3177) | −0.6% |
Mental disorders | 0.02 (0.01–0.02) | 0.04 (0.02–0.05) | 100.0% | 1734 (1290 - 2246) | 1732 (1283- 2239) | −0.1% | 1734 (1290 - 2246) | 1732 (1284 - 2239) | −0.1% |
Neurological disorders | 543.2 (500.6–578.8) | 391.8 (362.2–423.6) | −27.9% | 1117 (761–1526) | 1111 (748–1543) | −0.5% | 1660 (1310 - 2072) | 1503 (1136 - 1932) | −9.4% |
Diabetes and kidney diseases | 825.7 (758.4–901.3) | 460.2 (417.4–505.6) | −44.3% | 494.9 (348.6–680) | 539.8 (373–734.9) | 9.1% | 1321 (1156 - 1512) | 1000 (832–1206) | − 24.3% |
Other non-communicable diseases | 1020 (725–1272) | 298.5 (262.1–333.6) | −70.7% | 679.6 (466.5–959.7) | 595.6 (408.8–836.7) | −12.4% | 1699 (1314 - 2095) | 894 (706.4–1133) | −47.4% |
Chronic respiratory diseases | 519.2 (460.3–576.9) | 311.2 (276.1–344.2) | −40.0% | 484.5 (374.5–605.4) | 449.1 (352.8–556.9) | −7.3% | 1004 (880–1138) | 760.7 (659.9–870.2) | − 24.2% |
Skin and subcutaneous diseases | 19.7 (8.9–27.5) | 17.1 (8.8–21.7) | −13.2% | 564.9 (383.1–809.4) | 632.3 (433.7–902.8) | 11.9% | 584.7 (403.1–825.9) | 649.4 (449.4–916.9) | 11.1% |
Sense organ diseases | 0 | 0 | N/A | 531.5 (359.3–752.3) | 501.8 (339.8–715.5) | − 5.6% | 531.5 (359.3–752.3) | 501.8 (339.8–715.5) | −5.6% |
Digestive diseases | 474.1 (380.6–570.6) | 270.6 (241.7–302.6) | −42.9% | 204.5 (142.3–279.5) | 217.4 (152–298) | 6.3% | 678.7 (557.4–799.7) | 488 (419.4–576.7) | −28.1% |
Substance use disorders | 48 (37.9–61.2) | 69.3 (59–84) | 44.1% | 188.1 (131.1–252.3) | 199.7 (138.3–266.2) | 6.2% | 236.2 (178–298.7) | 268.9 (208.8–333.9) | 13.9% |